Table of Contents

Articles

• You have access

  Insights from a Three-Dimensional Model into Ligand Binding to Constitutive Active Receptor

  Li Xiao, Xiaoming Cui, Vincent Madison, Ronald E. White and K.-C. Cheng

  Drug Metabolism and Disposition September 2002, 30 (9) 951-956; DOI: https://doi.org/10.1124/dmd.30.9.951
• You have access

  The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450

  Barbara J. Ring, Jennifer S. Gillespie, Shelly N. Binkley, Kristina M. Campanale and Steven A. Wrighton

  Drug Metabolism and Disposition September 2002, 30 (9) 957-961; DOI: https://doi.org/10.1124/dmd.30.9.957
• You have access

  Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital Pretreatment

  Hao Xiong, Hiroshi Suzuki, Yuichi Sugiyama, Peter J. Meier, Gary M. Pollack and Kim L. R. Brouwer

  Drug Metabolism and Disposition September 2002, 30 (9) 962-969; DOI: https://doi.org/10.1124/dmd.30.9.962
• You have access

  Catalytic Specificity of CYP2D Isoforms in Rat and Human

  Toyoko Hiroi, Toshio Chow, Susumu Imaoka and Yoshihiko Funae

  Drug Metabolism and Disposition September 2002, 30 (9) 970-976; DOI: https://doi.org/10.1124/dmd.30.9.970
• You have access

  Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes

  Yuan Hua Wen, Jasminder Sahi, Ellen Urda, Shaila Kulkarni, Kelly Rose, Xianxian Zheng, Jacqueline F. Sinclair, Hongbo Cai, Stephen C. Strom and Vsevolod E. Kostrubsky

  Drug Metabolism and Disposition September 2002, 30 (9) 977-984; DOI: https://doi.org/10.1124/dmd.30.9.977
• You have access

  Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4

  Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert

  Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985
• You have access

  N-Glucuronidation of Nicotine and Cotinine in Human: Formation of Cotinine Glucuronide in Liver Microsomes and Lack of Catalysis by 10 Examined UDP-Glucuronosyltransferases

  Omar Ghosheh and Edward M. Hawes

  Drug Metabolism and Disposition September 2002, 30 (9) 991-996; DOI: https://doi.org/10.1124/dmd.30.9.991
• You have access

  Effects of Dexamethasone on Aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-Sulfotransferase Gene Expression in Primary Cultured Human Hepatocytes

  Zhengbo Duanmu, Deborah Locke, Jeffrey Smigelski, Wei Wu, Michael S. Dahn, Charles N. Falany, Thomas A. Kocarek and Melissa Runge-Morris

  Drug Metabolism and Disposition September 2002, 30 (9) 997-1004; DOI: https://doi.org/10.1124/dmd.30.9.997
• You have access

  Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-Glucuronosyltransferases

  Kenneth F. Ilett, Brian T. Ethell, James L. Maggs, Timothy M. E. Davis, Kevin T. Batty, Brian Burchell, Tran Quang Binh, Le Thi Anh Thu, Nguyen Canh Hung, Munir Pirmohamed, B. Kevin Park and Geoffrey Edwards

  Drug Metabolism and Disposition September 2002, 30 (9) 1005-1012; DOI: https://doi.org/10.1124/dmd.30.9.1005
• You have access

  Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human

  Josh J. Yuan, Dai-chang Yang, Ji Y. Zhang, Roy Bible, Aziz Karim and John W. A. Findlay

  Drug Metabolism and Disposition September 2002, 30 (9) 1013-1021; DOI: https://doi.org/10.1124/dmd.30.9.1013
• You have access

  Sexual Dimorphism and Tissue Specificity in the Expression of CYP4F Forms in Sprague Dawley Rats

  Auinash Kalsotra, Sayeepriyadarshini Anakk, Christopher L. Boehme and Henry W. Strobel

  Drug Metabolism and Disposition September 2002, 30 (9) 1022-1028; DOI: https://doi.org/10.1124/dmd.30.9.1022
• You have access

  Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element

  Wafaa El-Sankary, Vincent Bombail, G. Gordon Gibson and Nick Plant

  Drug Metabolism and Disposition September 2002, 30 (9) 1029-1034; DOI: https://doi.org/10.1124/dmd.30.9.1029
• You have access

  Metabolism of the Endocrine Disruptor Pesticide-Methoxychlor by Human P450s: Pathways Involving a Novel Catechol Metabolite

  Yiding Hu and David Kupfer

  Drug Metabolism and Disposition September 2002, 30 (9) 1035-1042; DOI: https://doi.org/10.1124/dmd.30.9.1035